Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
News | 30 July 2012
PALATINE, IL, Jul 30, 2012 (MARKETWIRE via COMTEX) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) , a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
